BioGenCell Europe SA (Public limited company)
BioGenCell Europe SA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0678.674.356. It was founded on 18-07-2017. Its registered office is in Waterloo. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 61 045 and a loss of € 8 922. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 14-10-2026.
Company information
Key figures of BioGenCell Europe SA
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -8 922-48 % | € -6 021+31 % | € -8 676-6 % | € -8 206 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 61 045-13 % | € 69 966-8 % | € 75 988-10 % | € 84 664 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 386 698+1 % | € 383 665-1 % | € 387 295-1 % | € 391 689 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -8 240-52 % | € -5 427+33 % | € -8 112-7 % | € -7 587 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Waterloo.
| Company | Town |
|---|---|
| RECHERCHE ET SANTE | 1410 Waterloo |
| OTORINO | 1410 Waterloo |
| ONCODERMA | 1410 Waterloo |
| ADVANCED MEDICAL DIAGNOSTICS | 1410 Waterloo |
| W | 1410 Waterloo |
| ELEONOR | 1410 Waterloo |
| COMPETENCES ET EQUILIBRE | 1410 Waterloo |
| RHUMAT-OS | 1410 Waterloo |
Frequently asked questions
Is BioGenCell Europe SA still active? Yes. The Crossroads Bank for Enterprises lists BioGenCell Europe SA as active.
What is the VAT number of BioGenCell Europe SA? The VAT number of BioGenCell Europe SA is BE 0678.674.356.
When was BioGenCell Europe SA founded? BioGenCell Europe SA was founded on 18-07-2017.
What is the address of BioGenCell Europe SA? The current registered office of BioGenCell Europe SA is Avenue Louis David 68, 1410 Waterloo.
When did BioGenCell Europe SA last file annual accounts? The latest annual accounts of BioGenCell Europe SA were filed on 26-03-2026.
Does BioGenCell Europe SA file its annual accounts on time? Yes. BioGenCell Europe SA filed its annual accounts within the legal deadline for each of its last 4 financial years.
Is BioGenCell Europe SA financially healthy? Addrly gives BioGenCell Europe SA a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is BioGenCell Europe SA profitable? The annual accounts of BioGenCell Europe SA for 2025 show a loss of € 8 922.
What is the equity of BioGenCell Europe SA? The equity of BioGenCell Europe SA was € 61 045 at the close of the 2025 financial year.
Who are the directors of BioGenCell Europe SA? The annual accounts of BioGenCell Europe SA record 4 mandates. The names, roles and dates are visible with a free account.
Can BioGenCell Europe SA receive Peppol e-invoices? Yes. BioGenCell Europe SA is registered on the Peppol network and can receive structured electronic invoices.
What does BioGenCell Europe SA do? The main activity of BioGenCell Europe SA is: Scientific research and development.